Crossmark

Comparative efficacy and safety of distinct PD-1 antibodies in unresectable advanced or recurrent gastric and gastroesophageal junction cancer: a network meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s12876-025-04376-y

Published Online: 2025-11-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Mengting

Li, Jun

Shen, Shiju

Chen, Linshan

Jia, Bo
License Information

Text and Data Mining valid from 2025-11-28

Version of Record valid from 2025-11-28
More Information

Article History

Received: 10 August 2025

Accepted: 3 October 2025

First Online: 28 November 2025

Declarations

:

: This is a systematic review and meta-analysis, ethics approval and consent to participate are not applicable.

: Not applicable. The manuscript does not include the participant’s identification image or other personal or clinical details.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below